Form 4 for CTSO Cytosorbents Corp
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-18 · accession 0001104659-23-102316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-20 | 2023-09-18 | CTSO | BLOCH KATHLEEN P. | CFO | A - Grant | $0.00 | +45.0K | 442.3K | +11% | $0 |
| D | 2023-09-20 | 2023-09-18 | CTSO | BLOCH KATHLEEN P. | CFO | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-18 | A | A | 45,000 | $0.00 | 442,347 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") which shall vest as follows: (i) 25,000 RSUs shall vest on the date of grant, (ii) 10,000 RSUs shall vest on the first anniversary of the date of grant, and (iii) 10,000 RSUs shall vest on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock, par value $0.001 per share (the "Common Stock") of CytoSorbents Corporation (the "Company") upon vesting. (F2) Includes: (i) the following RSUs that will be settled into Common Stock upon a "Change In Control" of the Company, as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015; (F4) (continued from footnote 3) (iii) 197,347 shares of Common Stock owned by the Reporting Person. (F3) (continued from footnote 2) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: 18,500 RSUs granted on August 10, 2022; and |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-09-18 | A | A | 30,000 | $0.00 | 30,000 | D | $1.98 · — to 2033-09-18 | 30,000 Common Stock | (F5) These stock options were granted pursuant to the Plan. The shares underlying these stock options shall vest as follows: (i) 10,000 shares underlying these stock options shall vest on the date of grant, (ii) 10,000 shares underlying these stock options shall vest on the first anniversary of the date of grant, and (iii) 10,000 underlying these stock options shall vest on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date. |